Moderator: Adam Rutherford – Science Author and BBC Broadcaster
FROM DATA TO INSIGHTS – AN INTRODUCTION
The data revolution in life science and healthcare. The determinants of health. Precision medicine in oncology and the value of health data. Understanding life in the era of large-scale studies. Who are the new players in life science and who will lead the race?
- Adam Rutherford – Science Author and BBC Broadcaster
- Sarah Neville – Pharmaceutical Editor at Financial Times
- Mathias Uhlén – Professor of Microbiology at KTH Royal Institute of Technology
- Kamal Obbad – CEO of Nebula Genomics
- Stefan Fröhling – Managing Director of NCT Heidelberg and Head of the division of Translational Medical Oncology
- Cecilia Magnusson, Group leader for Prevention, Intervention and Mechanisms in Public Health at Karolinska Institutet
CASES: HOW CAN WE USE DATA IN NEW WAYS TODAY AND IN THE FUTURE? WHAT ARE THE OPPORTUNITIES AND THE ASSOCIATED RISKS?
The microbiome of planet Earth. Using data in novel ways to understand human behaviour. The use of human, biological data in research and healthcare – opportunities, risks and ethical considerations. Facts, beliefs and opinions – what shapes our thinking?
- Janet Jansson – Chief Scientist for Biology and Laboratory Fellow at Pacific Northwest National Laboratory
- Suzanne Gage – Department for Psychological Sciences at the University of Liverpool
- Mark Thomas – Professor of Evolutionary Genetics, University College London
- Åsa Wikforss – Professor in Theoretical Philosophy at Stockholm University
- Mats G. Hansson – Professor of Biomedical Ethics at the Centre for Research Ethics and Bioethics at Uppsala University
SUMMARY AND CONCLUSIONS
- Stefan Nordlund – Professor in Biochemistry at Stockholm University and Member of the Board at Stockholm Science City Foundatio